Valley Diagnostics
Our mission is earlier detection and diagnosis of disease, opening the doors to a longer, healthier and happier life
About us at Valley Diagnostics
Valley Diagnostics is working with a range of contributors, collaborators and partners to bring to market next generation lateral flow diagnostic kits, combined with smartphone technology for reading test results and software for capturing and managing subject data, all for deployment in screening programs, in “point-of-care” and “at-home” use.
Products will test for patent-protected biomarkers that identify human and animal diseases allowing for very early detection and diagnosis of disease.
Some of the products we are working on are highlighted below. If you want to know more, just contact us.
Products in development
Who we are
A passionate team of scientists and product developers on a serious mission
Our team and wider collaborators includes world renowned metabolomics researchers, experts in antigenic translation, antibody development and production, assay development and production, a range of novel lateral flow technologies, machine learning and user facing mobile app technology and data capture systems.
What we do
Application of advanced and novel technologies to redefine early testing for disease
Our team and wider collaborators manage the whole product development lifecycle, from biomarker fingerprinting with the highest AUC, followed by the applied chemistry process to translate analytes into antigenic molecules for antibody preparation.
Antibodies are conjugated to produce the immunoassay for building into a lateral flow test using a range of test methods to detect multiple biomarkers.
We apply regulator-approved Computer Vision and Machine Learning algorithms deployed via smartphone apps and cloud-based computing to capture, manage, analyse and report test result data with an app, cloud and dashboard software platform designed for medical-grade regulatory compliance.
"We want to make a difference to human and animal healthcare, to help identify disease early, to enable intervention when it can make a real difference."
Dave Taylor. Founder and CEO
The process
The elements that make up the products
1
Sector leading metabolomics research in the discovery and identification of biomarker signatures for human and and animal diseases.
2
Translational science and purification services for the conjugation of the biomarker analytes in order to prepare antigenic molecules for antibody preparation.
3
Antibody development, antibody production, assay solutions and packaging of kits for the immuno-assays.
4
A range of innovative lateral flow technologies selected to offer the most appropriate solution for the test requirements.
5
Deployment of an MHRA approved, AI-powered, digital smartphone reader.
6
Deployment of a fully developed data management software platform called “Transform”, uniquely built to Software as a Medical Device (“SaMD”) standard for lateral flow test data capture and reporting.
Our impact
Benefiting the community - locally and globally
We want to deploy our products wordwide, so that we can bring the benefits of early, low cost, easy to use and manage disease screening to the widest audience. We know that our products can help to improve health outcomes for people and animals wherever they are and whatever their circumstances.
